Innatoss and MediSapiens Receive EU Grant to Personalize Lyme Diagnostics

Innatoss and MediSapiens have partnered to develop a novel Lyme borreliosis clinical interpretation and communication solution.  The development is supported by the PERMIDES (Personalised Medicine Innovation through Digital Enterprise Solutions) project, funded by the European Union. Read more